查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609122

霉浆菌测试市场：按产品/服务、技术、应用和最终用户划分 - 全球预测 2025-2030 年

Mycoplasma Testing Market by Product & Service (Assays, Kits, & Reagents, Instruments, Services), Technique (Direct DNA Staining, Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年霉浆菌检测市场价值为10亿美元，预计2024年将达10.8亿美元，复合年增长率为8.29%，预计2030年将达到17.5亿美元。

霉浆菌检测透过检测可能损害产品品质和病人安全的污染，在确保生技药品、疫苗和细胞疗法的安全性和有效性方面发挥关键作用。这种需求源自于製药和生技产业严格的监管要求和品质保证标准，推动了对可靠测试解决方案的需求。主要应用包括细胞培养和疫苗製造，其中污染可能导致批次失败和巨大的财务损失。最终用途包括製药公司、研究机构、委託研究组织等。慢性病的增加、生物製药製造的进步以及对个人化医疗的日益关注对市场成长产生了重大影响。此外，基于 PCR 的技术和测试程序自动化等技术进步也带来了潜在的成长机会。次世代定序(NGS) 和就地检验的创新可以为相关人员提供竞争优势。然而，挑战仍然存在，例如先进检测工具的高成本、处理不同霉浆菌物种的复杂性以及地区之间严格的监管环境，这些环境可能会阻碍市场扩张。为了抓住新的机会，公司必须投资研发，以开发具有成本效益、快速且灵敏的检测方法。与生物技术公司和研究机构的合作也可以支持技术进步。关键是要集中精力进行地理扩张，以开拓开拓的市场，并保持对不同地区监管机构的严格遵守。总体而言，霉浆菌检测市场本质上正在快速发展，强调准确性和技术集成，为技术创新提供了有吸引力的空间。优先领域包括开发用户友好的快速检测套件和自动化系统，它们有可能从根本上改变测试通讯协定并提高效率和可靠性。在这些领域竞争考察的策略投资可以产生显着的长期效益并推动竞争优势。

主要市场统计
基准年[2023] 10亿美元
预计年份 [2024] 10.8亿美元
预测年份 [2030] 17.5亿美元
复合年增长率（%） 8.29%

市场动态：快速发展的霉浆菌检测市场的关键市场洞察

霉浆菌检测市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 霉浆菌相关疾病增加
    • 生物技术和製药行业对品管的需求不断增加
    • 霉浆菌检测在细胞培养和疫苗生产中的重要性日益增加
  • 市场限制因素
    • 昂贵的诊断技术，仅适用于有限的技术人员
  • 市场机会
    • 透过与霉浆菌检测中的人工智慧和机器学习相结合，增强资料分析和结果解释
    • 高通量检测和减少手动错误的自动化开发
  • 市场挑战
    • 确保不断进化的霉浆菌菌株的测试性能一致

波特五力战略工具驾驭霉浆菌检测市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解霉浆菌侦测市场的外部影响

外部宏观环境因素在塑造霉浆菌检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解霉浆菌侦测市场的竞争状况

对霉浆菌测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵霉浆菌侦测市场供应商绩效评估

FPNV 定位矩阵是评估霉浆菌测试市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製霉浆菌检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，霉浆菌测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 霉浆菌相关疾病的传播
      • 生物技术和製药行业对品管的需求不断增加
      • 霉浆菌检测在细胞培养和疫苗生产中的重要性日益增加
    • 抑制因素
      • 诊断技术昂贵且专业知识有限。
    • 机会
      • 将人工智慧和机器学习整合到霉浆菌测试中可增强资料分析和结果解释
      • 开发高通量测试自动化并减少手动错误
    • 任务
      • 确保不断进化的霉浆菌菌株的测试性能一致
  • 市场区隔分析
    • 使用 PCR 技术进行霉浆菌检测，以获得快速、准确的临床结果
    • 製药和生物技术领域越来越多地采用霉浆菌检测来开发细胞疗法
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章霉浆菌检测市场：依产品及服务分类

  • 测定、套件和试剂
  • 装置
    • DNA定序仪
    • 酵素连结免疫吸附测定仪
    • 萤光显微镜
    • PCR系统
  • 服务
    • 认证和检验服务
    • 咨询服务
    • 测试服务

第七章霉浆菌检测市场：依技术分类

  • 直接DNA染色
  • 酵素免疫分析法
  • 核酸检测
  • 聚合酵素链锁反应

第八章霉浆菌检测市场：依应用分类

  • 细胞株测试
  • 药物发现与开发
  • 病毒测试

第九章霉浆菌检测市场：依最终用户分类

  • 学术研究所
  • 细胞库和实验室
  • 合约调查机构
  • 製药和生物技术公司

第十章美洲霉浆菌检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区霉浆菌检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲霉浆菌检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • AnaBioTec 和 BioMerieux 透过先进的 NAT 技术和全面的检验服务彻底改变了霉浆菌测试
    • QIAGEN 推出全新 QIAcuity 数位 PCR套件，以提高安全检测解决方案的准确性和效率
  • 战略分析和建议

公司名单

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, Inc.
  • Bionique Testing Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Genecopoeia, Inc.
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Minerva Biolabs GmbH
  • MP Biomedicals, LLC
  • Mycoplasma Experience Limited
  • Nelson Laboratories Fairfield, Inc.
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Savyon Diagnostics
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Wuxi AppTec
Product Code: MRR-FB6C9E7934EF

The Mycoplasma Testing Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.08 billion in 2024, and is projected to grow at a CAGR of 8.29%, to USD 1.75 billion by 2030.

Mycoplasma testing plays a crucial role in ensuring the safety and efficacy of biologics, vaccines, and cell-based therapies by detecting contamination, which could compromise product quality and patient safety. Necessity arises from stringent regulatory requirements and quality assurance standards in pharmaceuticals and biotechnology industries, propelling demand for reliable testing solutions. Key applications include cell culture and vaccine production, where any contamination can lead to batch failures and substantial financial loss. End-use scope encompasses pharmaceutical companies, research institutes, and contract research organizations. Market growth is predominantly influenced by the increasing prevalence of chronic diseases, advancements in biopharmaceutical production, and a rising focus on personalized medicine. Furthermore, technological advancements such as PCR-based methods and automation in testing procedures present potential opportunities for growth. Innovations in next-generation sequencing (NGS) and point-of-care testing can provide competitive advantages to stakeholders. However, challenges persist, including high costs of advanced testing tools, the complexity of dealing with different mycoplasma species, and stringent regulatory landscapes across regions, which may hinder market expansion. To leverage emerging opportunities, businesses must invest in R&D to develop cost-effective, rapid, and highly sensitive detection methods. Collaboration with biotechnology companies and research organizations can also aid in technological advancements. A focused effort on regional expansion to tap into underpenetrated markets and maintaining robust compliance with regulatory bodies across different geographies will be key. Overall, the mycoplasma testing market by nature is rapidly evolving, with an emphasis on precision and technological integration, presenting an attractive space for innovation. Priority areas include the development of user-friendly, rapid detection kits and automated systems, which could radically transform testing protocols and improve efficiency and reliability. Insight-driven strategic investment in these areas could harness significant long-term gains and drive the competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 1.00 billion
Estimated Year [2024] USD 1.08 billion
Forecast Year [2030] USD 1.75 billion
CAGR (%) 8.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mycoplasma Testing Market

The Mycoplasma Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of mycoplasma related diseases
    • Rising demand for quality control in biotechnology and pharmaceutical industry
    • Growing importance of mycoplasma testings in cell culture and vaccine production
  • Market Restraints
    • Expensive diagnostics technique and limited availability of technical experties
  • Market Opportunities
    • Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
    • Development of automation for high throughput testings and reducing manual errors
  • Market Challenges
    • Ensuring consistent performance of test among evolving mycoplasma strains

Porter's Five Forces: A Strategic Tool for Navigating the Mycoplasma Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mycoplasma Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mycoplasma Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mycoplasma Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mycoplasma Testing Market

A detailed market share analysis in the Mycoplasma Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mycoplasma Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mycoplasma Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mycoplasma Testing Market

A strategic analysis of the Mycoplasma Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mycoplasma Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioFire Diagnostics, Inc., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genecopoeia, Inc., InvivoGen, Lonza Group Ltd., Merck KGaA, Meridian Bioscience, Inc., Minerva Biolabs GmbH, MP Biomedicals, LLC, Mycoplasma Experience Limited, Nelson Laboratories Fairfield, Inc., Norgen Biotek Corporation, Promocell GmbH, Savyon Diagnostics, Takara Bio Inc., Thermo Fisher Scientific, Inc., and Wuxi AppTec.

Market Segmentation & Coverage

This research report categorizes the Mycoplasma Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Assays, Kits, & Reagents, Instruments, and Services. The Instruments is further studied across DNA Sequencers, ELISA Readers, Fluorescent Microscopes, and PCR Systems. The Services is further studied across Certification & Validation Services, Consulting Services, and Testing Services.
  • Based on Technique, market is studied across Direct DNA Staining, Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing, and Polymerase Chain Reaction.
  • Based on Application, market is studied across Cell Line Testing, Drug Discovery & Development, and Virus Testing.
  • Based on End-User, market is studied across Academic & Research Institutes, Cell Banks & Laboratories, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of mycoplasma related diseases
      • 5.1.1.2. Rising demand for quality control in biotechnology and pharmaceutical industry
      • 5.1.1.3. Growing importance of mycoplasma testings in cell culture and vaccine production
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive diagnostics technique and limited availability of technical experties
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration with AI and machine learning in mycoplasma testings for enhancements in data analysis and result interpretation
      • 5.1.3.2. Development of automation for high throughput testings and reducing manual errors
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring consistent performance of test among evolving mycoplasma strains
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Usage of PCR techniques in mycoplasma testings for rapid and precise clinical results
    • 5.2.2. Rising adoption of mycoplasma testings in pharmaceutical & biotechnology sectors for cell therapy development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mycoplasma Testing Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
    • 6.3.1. DNA Sequencers
    • 6.3.2. ELISA Readers
    • 6.3.3. Fluorescent Microscopes
    • 6.3.4. PCR Systems
  • 6.4. Services
    • 6.4.1. Certification & Validation Services
    • 6.4.2. Consulting Services
    • 6.4.3. Testing Services

7. Mycoplasma Testing Market, by Technique

  • 7.1. Introduction
  • 7.2. Direct DNA Staining
  • 7.3. Enzyme-Linked Immunosorbent Assay
  • 7.4. Nucleic Acid Testing
  • 7.5. Polymerase Chain Reaction

8. Mycoplasma Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Line Testing
  • 8.3. Drug Discovery & Development
  • 8.4. Virus Testing

9. Mycoplasma Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Cell Banks & Laboratories
  • 9.4. Contract Research Organizations
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Mycoplasma Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mycoplasma Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Mycoplasma Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. AnaBioTec and bioMerieux revolutionize mycoplasma testing with advanced NAT technologies and comprehensive validation services
    • 13.3.2. QIAGEN launches new QIAcuity digital PCR kits, enhancing accuracy and efficiency of safety testing solutions
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam plc
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. BioFire Diagnostics, Inc.
  • 5. Bionique Testing Laboratories, Inc.
  • 6. Charles River Laboratories International, Inc.
  • 7. Creative Bioarray
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche AG
  • 10. Genecopoeia, Inc.
  • 11. InvivoGen
  • 12. Lonza Group Ltd.
  • 13. Merck KGaA
  • 14. Meridian Bioscience, Inc.
  • 15. Minerva Biolabs GmbH
  • 16. MP Biomedicals, LLC
  • 17. Mycoplasma Experience Limited
  • 18. Nelson Laboratories Fairfield, Inc.
  • 19. Norgen Biotek Corporation
  • 20. Promocell GmbH
  • 21. Savyon Diagnostics
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific, Inc.
  • 24. Wuxi AppTec

LIST OF FIGURES

  • FIGURE 1. MYCOPLASMA TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. MYCOPLASMA TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MYCOPLASMA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MYCOPLASMA TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DNA SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ELISA READERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY FLUORESCENT MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CERTIFICATION & VALIDATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DIRECT DNA STAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL LINE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY VIRUS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CELL BANKS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023